Skip to content
value.today

Applied DNA Sciences Inc.

Total raised
$9 M
3 rounds on record
Latest round
$2 M
Nov 2012
First round on record
Jul 2011
Today
Went public
See the company page

Applied DNA Sciences Inc. is listed today as BNB Plus Corp.: market value, financials and filings are on its company page.

Funding rounds

3 counted as startup funding, 8 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Applied DNA Sciences Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2026$3 MPrivate placement after listing$2 to $10 million

Applied DNA Sciences Inc.: Private sale, May 2026

Investors in this round

1 investor had bought by the notice of Jun 3, 2026: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Beth M. Jantzen · Executive Officer
  • Clay D. Shorrock · Executive Officer
  • James D. Haft · Director
  • Joseph D. Ceccoli · Director
  • Joshua D. Kruger · Director
  • Judith D. Murrah · Director
  • Robert B. Catell · Director
  • Yacov A. Shamash · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Clay D. Shorrock, President and CEO. Source: SEC Form D, newest notice filed Jun 3, 2026. Read the notice at the SEC.

equity, optionsSEC
Sep 2025$58 MPrivate placement after listing$50 to $250 million

Applied DNA Sciences Inc.: Private sale, Sep 2025

Investors in this round

33 investors had bought by the notice of Oct 15, 2025: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$58 M of $58 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$361,745
Finders' fees
none
Paid to its own people
$725,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Beth Jantzen · Executive Officer · Chief Financial Officer
  • Clay Shorrock · Executive Officer · Chief Executive Officer
  • Judith Murrah · Executive Officer, Director · Chairperson of the Board, Strategic Transition Advisor
  • Elizabeth M. Schmalz Shaheen · Director
  • Joseph D. Ceccoli · Director
  • Robert B. Catell · Director
  • Yacov A. Shamash · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Lucid Capital Markets, LLC (CRD 000140345) · New York, New YorkSold in AZ, CA, CT, FL, IL, KY, NY, PR, TX, VT

Remarks in the notice

  • On the amounts: “Reflects estimated proceeds from the sale of shares of the Company's common stock, par value $0.001 per share and/or pre-funded warrants and Series E Warrants, if all Series E Warrants were exercised.”
  • On the use of proceeds: “Includes a total gross amount of (i) $400,000 to be paid in a lump sum to Ms. Murrah on or before November 17, 2025; (ii) $175,000 to be paid as a one-time cash bonus to Mr. Shorrock; and (iii) $150,000 to be paid as a one-time cash bonus to Ms. Jantzen”

Signed by Beth Jantzen, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 15, 2025. Read the notice at the SEC.

equity, optionsSEC
Oct 2020$1 MPrivate placement after listingUnder $2 million

Applied DNA Sciences Inc.: Private sale, Oct 2020

Investors in this round

2 investors had bought by the notice of Oct 20, 2020: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Beth A. Jantzen · Executive Officer · Chief Financial Officer
  • James A. Hayward · Executive Officer, Director · Chairman, CEO and President
  • Judith A. Murrah · Executive Officer · Chief Information Officer
  • Elizabeth M. Schmalz Ferguson · Director
  • John A. Bitzer, III · Director
  • Joseph D. Ceccoli · Director
  • Robert B. Catell · Director
  • Sanford R. Simon · Director
  • Scott D. Anchin · Director
  • Yacov A. Shamash · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “On October 7, 2020, 159,000 warrants to purchase common stock were issued at an exercise price of $7.54. Up to 330,500 additional warrants may be issued, at an exercise price determined on the date of issuance, estimated at $7.54.”

Signed by Beth Jantzen, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 20, 2020. Read the notice at the SEC.

equity, optionsSEC
Jul 2019$2 MPrivate placement after listingUnder $2 million

Applied DNA Sciences Inc.: Private sale, Jul 2019

Investors in this round

1 investor had bought by the notice of Jul 19, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Beth A. Jantzen · Executive Officer · Chief Financial Officer
  • James A. Hayward · Executive Officer, Director · Chairman, CEO and President
  • Judith A. Murrah · Executive Officer · Chief Information Officer
  • Charles S. Ryan · Director
  • Elizabeth M. Schmalz Ferguson · Director
  • John A. Bitzer, III · Director
  • Joseph D. Ceccoli · Director
  • Robert B. Catell · Director
  • Sanford R. Simon · Director
  • Yacov A. Shamash · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Beth Jantzen, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 19, 2019. Read the notice at the SEC.

debt, optionsSEC
Aug 2018$2 MPrivate placement after listingUnder $2 million

Applied DNA Sciences Inc.: Private sale, Aug 2018

Investors in this round

11 investors had bought by the notice of Sep 4, 2018: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Beth A. Jantzen · Executive Officer · Chief Financial Officer
  • James A. Hayward · Executive Officer, Director · Chairman, CEO and President
  • Judith A. Murrah · Executive Officer · Chief Information Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Beth Jantzen, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 4, 2018. Read the notice at the SEC.

debt, optionsSEC
Nov 2016$5 MPrivate placement after listing$2 to $10 million

Applied DNA Sciences Inc.: Private sale, Nov 2016

Investors in this round

2 investors had bought by the notice of Nov 14, 2016: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Beth A. Jantzen · Executive Officer · Chief Financial Officer
  • James A. Hayward · Executive Officer, Director
  • Judith A. Murrah · Executive Officer · Chief Information Officer
  • Ming-Hwa Benjamin Liang · Executive Officer · Secretary and Chief Scientific Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group (CRD 120708) · New York, New YorkSold in NJ, NY
  • Imperial Capital, LLC (CRD 43744) · Los Angeles, CaliforniaSold in NJ, NY

Remarks in the notice

  • On fees: “7% and 68,182 warrants each to purchase one share of Common Stock”

Signed by Beth Jantzen, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 14, 2016. Read the notice at the SEC.

equity, optionsSEC
Jun 2014$2 MPrivate placement after listing$2 to $10 million

Applied DNA Sciences Inc.: Private sale, Jun 2014

Investors in this round

22 investors had bought by the notice of Jun 17, 2014: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$5,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$245,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James A Hayward · Executive Officer, Director
  • Judy BENJAMIN Murrah · Executive Officer
  • Karol Benjamin Gray · Executive Officer
  • Ming-Hwa Benjamin Liang · Executive Officer
  • Charles Benjamin Ryan · Director
  • John Benjamin Bitzer, Iii · Director
  • Sanford R. Simon · Director
  • Yacov Benjamin Shamash · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “INCLUDES WARRANTS AT NO ADDITIONAL CONSIDERATION.”
  • On the use of proceeds: “estimate of proceeds that may be used for salaries of executive officers”

Signed by James A. Hayward, Chief executive officer. Source: SEC Form D, newest notice filed Jun 17, 2014. Read the notice at the SEC.

equity, optionsSEC
Jul 2013$8 MPrivate placement after listing$2 to $10 million

Applied DNA Sciences Inc.: Private sale, Jul 2013

Investors in this round

0 investors had bought by the notice of Aug 2, 2013: 0 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
$2,000,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$170,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James A Hayward · Executive Officer, Director
  • Kurt R. Jensen · Executive Officer
  • Ming-Hwa Benjamin Liang · Executive Officer
  • Charles Benjamin Ryan · Director
  • John Benjamin Bitzer, Iii · Director
  • Karol Benjamin Gray · Director
  • Sanford R. Simon · Director
  • Yacov Benjamin Shamash · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$2 MILLION IN COMMON STOCK HAS BEEN SOLD, AS WELL AS WARRANTS AT NO ADDITIONAL CONSIDERATION. $5.5 MILLION IN NEWLY-CREATED SERIES B CONVERTIBLE PREFERRED STOCK HAS ALSO BEEN SOLD.”

Signed by James A. Hayward, Chief executive officer. Source: SEC Form D, newest notice filed Aug 2, 2013. Read the notice at the SEC.

equity, optionsSEC
Nov 2012$2 MNo. 3$2 to $10 million

Applied DNA Sciences Inc.: Raise no. 3, Nov 2012

Investors in this round

0 investors had bought by the notice of Dec 13, 2012: 0 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $8 M offered; $6 M still to sell
Smallest investment taken
$2,000,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James A Hayward · Executive Officer, Director
  • Kurt R. Jensen · Executive Officer
  • Ming-Hwa Benjamin Liang · Executive Officer
  • Charles Benjamin Ryan · Director
  • Gerald Benjamin Catenacci · Director
  • John Benjamin Bitzer, Iii · Director
  • Karol Benjamin Gray · Director
  • Sanford R. Simon · Director
  • Yacov A Shamash · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$2 MILLION IN COMMON STOCK HAS BEEN SOLD, AS WELL AS WARRANTS AT NO ADDITIONAL CONSIDERATION. $5.5 MILLION IN NEWLY-CREATED SERIES A CONVERTIBLE PREFERRED STOCK MAY BE SOLD CONTINGENT ON SATISFACTION OF CERTAIN CONDITIONS.”

Signed by Kurt H. Jensen, Chief financial officer. Source: SEC Form D, newest notice filed Dec 13, 2012. Read the notice at the SEC.

equity, optionsSEC
Jun 2012$2 MNo. 2Under $2 million

Applied DNA Sciences Inc.: Raise no. 2, Jun 2012

Investors in this round

1 investor had bought by the notice of Jul 9, 2012: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James A. Hayward · Executive Officer, Director
  • Kurt H. Jensen · Executive Officer · Chief Financial Officer
  • Ming-Hwa R. Liang · Executive Officer · Chief Technology Officer and Secretary
  • Charles H. Ryan · Director
  • Gerald H. Catenacci · Director
  • John H. Bitzer, III · Director
  • Karol H. Gray · Director
  • Sanford R. Simon · Director
  • Yacov A. Shamash · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • No Sales Compensation · Stony Brook, New YorkSold in PA

Signed by Kurt H. Jensen, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 9, 2012. Read the notice at the SEC.

equitySEC
Jul 2011$5 MNo. 1$2 to $10 million

Applied DNA Sciences Inc.: Raise no. 1, Jul 2011

Investors in this round

6 investors had bought by the notice of Jul 19, 2011: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Applied DNA Sciences Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$265,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James A. Hayward · Executive Officer, Director
  • Kurt H. Jensen · Executive Officer · Chief Financial Officer
  • Ming-Hwa R. Liang · Executive Officer · Chief Technology Officer and Secretary
  • Sanford R. Simon · Director
  • Yacov A. Shamash · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • More than five · broker-dealer HALCYON CABOT PARTNERS, LTD. (CRD 32664) · New York, New YorkSold in NY, PA

Remarks in the notice

  • On fees: “commission includes a warrant to purchase 7,578,948 shares of common stock.”

Signed by Kurt H. Jensen, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 19, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Applied DNA Sciences Inc. had revenue between $1 million and $5 million when it filed its newest notice of a funding round (Jun 2026).

    SEC Form D (revenue range) · Jun 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2026

Products and services#

No products or services of Applied DNA Sciences Inc. are on record.

Investors#

1 named in official filings. Open an investor to see everything it has backed.

Investors in Applied DNA Sciences Inc.
InvestorKindAmountRoundRoleSource
KGPLA Holdings LLCOthernot statednot statedHeld Series B-1 preferred stock, 10% owner (Form 3, 2026)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 6 investors.

Largest shareholders today

Institutions holding BNB Plus Corp. shares, as of Jun 30, 2026.

Source: SEC Form 13F holdings reports · as of Jun 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Applied DNA Sciences Inc.
NameRoleNamed in
Beth M. JantzenExecutive officerJun 2026
Clay D. ShorrockExecutive officerJun 2026
Beth JantzenChief Financial OfficerOct 2025
Clay ShorrockChief Executive OfficerOct 2025
Judith MurrahChairperson of the Board, Strategic Transition AdvisorOct 2025
Beth A. JantzenChief Financial OfficerOct 2020
James A. HaywardChairman, CEO and PresidentOct 2020
Judith A. MurrahChief Information OfficerOct 2020
Ming-Hwa Benjamin LiangSecretary and Chief Scientific OfficerNov 2016
James A HaywardExecutive officerJun 2014
Judy BENJAMIN MurrahExecutive officerJun 2014
Karol Benjamin GrayExecutive officerJun 2014
Kurt R. JensenExecutive officerAug 2013
Kurt H. JensenChief Financial OfficerJul 2012
Ming-Hwa R. LiangChief Technology Officer and SecretaryJul 2012
James D. HaftDirectorJun 2026
Joseph D. CeccoliDirectorJun 2026
Joshua D. KrugerDirectorJun 2026
Judith D. MurrahDirectorJun 2026
Robert B. CatellDirectorJun 2026
Yacov A. ShamashDirectorJun 2026
Elizabeth M. Schmalz ShaheenDirectorOct 2025
Judith MurrahChairperson of the Board, Strategic Transition AdvisorOct 2025
Elizabeth M. Schmalz FergusonDirectorOct 2020
James A. HaywardChairman, CEO and PresidentOct 2020
John A. Bitzer, IIIDirectorOct 2020
Sanford R. SimonDirectorOct 2020
Scott D. AnchinDirectorOct 2020
Charles S. RyanDirectorJul 2019
Charles Benjamin RyanDirectorJun 2014
James A HaywardDirectorJun 2014
John Benjamin Bitzer, IiiDirectorJun 2014
Yacov Benjamin ShamashDirectorJun 2014
Karol Benjamin GrayDirectorAug 2013
Gerald Benjamin CatenacciDirectorDec 2012
Yacov A ShamashDirectorDec 2012
Charles H. RyanDirectorJul 2012
Gerald H. CatenacciDirectorJul 2012
John H. Bitzer, IIIDirectorJul 2012
Karol H. GrayDirectorJul 2012

About

American publicly traded digital asset management company listed on NASDAQ (BNBX).

Went public since 2012. Its SEC number is that of a company listed on a stock exchange.